Navigation Links
Inspire Announces Presentations at 2007 Association for Research in,Vision and Ophthalmology Annual Meeting

sters can be downloaded from Inspire's website, www.inspirepharm.com, following the conclusion of the conference. Additional information related to the ARVO conference can be obtained at www.arvo.org.

About Inspire

Inspire is a biopharmaceutical company dedicated to discovering, developing and commercializing prescription pharmaceutical products in disease areas with significant commercial potential and unmet medical needs. Inspire employs a U.S. sales force for the promotion of AzaSite(TM)(azithromycin ophthalmic solution) 1% for bacterial conjunctivitis, Elestat(R) (epinastine HCI ophthalmic solution) 0.05% for allergic conjunctivitis and Restasis(R) (cyclosporine ophthalmic emulsion) 0.05% for dry eye. Inspire is focused on the therapeutic areas of ophthalmology and respiratory/allergy, and is developing products for dry eye, cystic fibrosis, allergic rhinitis and glaucoma. Elestat and Restasis are trademarks owned by Allergan, Inc. AzaSite is a trademark owned by InSite Vision Incorporated. For more information, visit www.inspirepharm.com.

Forward-Looking Statements

The forward-looking statements in this news release relating to management's expectations and beliefs are based on preliminary information and management assumptions. Such forward-looking statements are subject to a wide range of risks and uncertainties that could cause results to differ in material respects, including those relating to product development, revenue, expense and earnings expectations, the seasonality of Elestat, intellectual property rights, adverse litigation developments, adverse developments in the U.S. Securities and Exchange Commission (SEC) investigation, competitive products, results and timing of clinical trials, success of marketing efforts, the need for additional research and testing, delays in manufacturing, funding, and the timing and content of decisions made by regulatory authorities, including the U.S. Food and Drug Administration. Further i
'"/>




Page: 1 2 3

Related medicine technology :

1. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
2. Inspire Announces Presentations at Two European Scientific Conferences
3. Inspire Announces Positive Results of Phase 2 Trial of Epinastine Nasal Spray for Seasonal Allergic Rhinitis
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
(Date:5/5/2015)... May 5, 2015  ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... three months ended March 31, 2015 and reaffirmed its ... for 2015. First Quarter 2015 Highlights Include: ... increase of 72% as compared to $10.9 million for ... adjusted non-GAAP EBITDA of $11.5 million, an increase of 170% ...
(Date:5/5/2015)... May 5, 2015 Tissue ... Group"), the regenerative medical devices company, announces that ... regional distribution contract for DermaPure® which is used ...      (Logo: http://photos.prnewswire.com/prnh/20150505/743321) , ... since Tissue Regenix received notice of Local Coverage ...
(Date:5/5/2015)... , May 5, 2015  Stryker Orthopaedics announced ... Ponte Vedra, FL.  Since becoming the ... Champions Tour" over one year ago, the company has ... Tour combined, with its onsite activation the Stryker Mobility ... on the importance of joint health. Proving to be ...
Breaking Medicine Technology:ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 2ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 3ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 4ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 5ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 6ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 7ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 8ANI Pharmaceuticals Reports First Quarter 2015 Financial Results 9Tissue Regenix Group plc: US Regional Distribution Agreement Signed 2Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 2Stryker Returns to TPC Sawgrass for THE PLAYERS Championship Alongside Former Tournament Winners Fred Funk and Hal Sutton 3
... following is a statement of Matthew L. Myers, ... http://photos.prnewswire.com/prnh/20080918/CFTFKLOGO ) (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ... and Drug Administration for taking appropriate enforcement action ... various violations of the Federal Food, Drug and ...
... Sept. 9 The U.S. Food and Drug ... Chloride (pralidoxime chloride), a drug used to treat ... agents). The drug is approved to be administered ... (Logo:   http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ...
Cached Medicine Technology:FDA Takes Appropriate Action to Regulate Electronic Cigarettes and Protect Public Health 2FDA Approves Pediatric Use of Chemical Poisoning Treatment 2
(Date:5/5/2015)... Burnie, MD (PRWEB) May 05, 2015 ... in an upcoming episode of Innovations with Ed Begley ... and show times TBA. , This segment will focus ... home testing. Viewers will learn about their AccuSom® home ... sleep test that provides continuous patient support and next-day ...
(Date:5/5/2015)... 2015 After record-breaking sales of ... Walgreens introduces the Cookies & Cream flavor at stores ... Nutrition has continually raised the bar for nutritional snacks. ... with an unprecedented nutritional profile, backed by international patents ... Nutrition will launch additional new products and expand retail ...
(Date:5/5/2015)... After conducting a nationwide executive search ... Smith, West Holt Medical Services in Atkinson, ... A skilled healthcare executive with more than 10 years ... on June 1st. , “Brad brings a proven track ... understanding and success in building strong relationships with physicians,” ...
(Date:5/5/2015)... Louis, MO (PRWEB) May 05, 2015 The ... 12, 2015 from 5:00 to 8:00 pm at the Rochester ... 50 hospitals, clinics and groups with career opportunities will be ... Attendees will enjoy free hors d’oeuvres and raffle prize drawings. ... says, “Rochester is an ideal location to hold a ...
(Date:5/5/2015)... Cincinnati, OH (PRWEB) May 05, 2015 ... healthcare ministry serving Ohio and Kentucky – has devoted ... Be Well videos to childhood obesity issues. Experts say ... In a concise video on Mercy Health’s YouTube channel, ... ,     Why is childhood obesity worse now ...
Breaking Medicine News(10 mins):Health News:Innovations with Ed Begley, Jr. to Explore NovaSom, Inc., in Upcoming Episode 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 2Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 3Health News:Nationwide Launch of Extend Nutrition’s Newest Bar Flavors Follows Most Successful New Item Sales in Company History 4Health News:West Holt Medical Services Hires New Chief Executive Officer 2Health News:West Holt Medical Services Hires New Chief Executive Officer 3Health News:PracticeMatch to Host Physician Career Fair at the Rochester Marriott on May 12, 2015 2Health News:PracticeMatch to Host Physician Career Fair at the Rochester Marriott on May 12, 2015 3Health News:Videos provide helpful information about childhood obesity 2
... on the target areas, where ADHD drugs act, researchers ... (PFC) region of the brain //rather than on accumbens ... University of Wisconsin-Madison found how the drug Ritalin used ... (ADHD), works in the brain. ,But ...
... with prostate cancer are more influenced by anecdote, misconception ... on clinical trial evidences. ,Research showed ... anecdotal experiences of others with prostate cancer to their ... entirely different from them are the reasons for waving ...
... Rheumatoid arthritis are also prone to have sexual problems. The ... against rheumatism congress. ,Rheumatoid arthritis occurs in elderly ... and inflammation of the joints. It is a chronic disease ... ,According to the study it was found that ...
... that was begun some six years ago has finally begun ... by mobile doctors //thereby getting the care they need without ... of a 33-foot-vehicle that would travel to schools in Garland, ... This has helped teens to get the care they need ...
... properly funding the cholesterol lowering drugs to the new Zealanders. ... which they point out the shortsighted approach of the agency ... and Dr Harvey White said that the agency did not ... years. ,Statins are drugs which help in the ...
... P. Viswanatham Government Medical College Hospital not in the list ... // ,There is an increased bitterness among the ... ministry of health of not including K. A. P. Viswanatham ... with the ,All India Institute of Medical Sciences (AIIMS), New ...
Cached Medicine News:Health News:Effect of ADHD Drugs on the Brain - Study Finds 2Health News:Effect of ADHD Drugs on the Brain - Study Finds 3Health News:Misconception on Treatment Options among Prostate Cancer Patients 2Health News:Increased Demand For Up-gradation Local Hospital In Tiruchy 2
Inorganic phosphorus reagent is used for the quantitative determination of inorganic phosphorus in human serum....
Gamma Glutamyl Transferase reagent is used for the quantitative determination of Gamma -GT in human serum....
For the kinetic quantitative determination of g-Glutamyl Transferase in serum for manual and/or automated procedures....
g-GT Liquid Reagent (Kinetic Method). Wavelength: 405 nm. Linear range: 0-200 U/mL. Prepare Working Reagent in the ratio of 5 parts R1 to 1 part of R2, (i.e., 50 mL R1 and 10 mL R2)....
Medicine Products: